Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Paola Cipriani, Piero Ruscitti, Francesco Carubbi, Vasiliki Liakouli & Roberto Giacomelli. (2014) Methotrexate: an old new drug in autoimmune disease. Expert Review of Clinical Immunology 10:11, pages 1519-1530.
Read now
Read now
Ignazio Olivieri, Salvatore D'Angelo, Carlo Palazzi & Angela Padula. (2009) Treatment strategies for early psoriatic arthritis. Expert Opinion on Pharmacotherapy 10:2, pages 271-282.
Read now
Read now
Jane Zochling & Jürgen Braun. (2006) Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis. Expert Opinion on Pharmacotherapy 7:7, pages 869-883.
Read now
Read now
J. Braun, X. Baraliakos, G. Godolias & H. Böhm. (2005) Therapy of ankylosing spondylitis – a review. Part I: Conventional medical treatment and surgical therapy. Scandinavian Journal of Rheumatology 34:2, pages 97-108.
Read now
Read now
E Rejón, MD Giménez, L Mayordomo, S Rodríguez, MP González & JL Marenco. (2004) Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement. Scandinavian Journal of Rheumatology 33:5, pages 323-326.
Read now
Read now
Éric Toussirot & Daniel Wendling. (2003) Recent progress in ankylosing spondylitis treatment. Expert Opinion on Pharmacotherapy 4:1, pages 1-12.
Read now
Read now
Articles from other publishers (43)
Wilson Bautista-Molano, Daniel G. Fernández-Ávila, María Lorena Brance, María Gabriela Ávila Pedretti, Ruben Burgos-Vargas, Inés Corbacho, Vanesa Laura Cosentino, José Francisco Díaz Coto, Enrique Giraldo Ho, Gustavo Gomes Resende, Luis Arturo Gutiérrez, Marwin Gutiérrez, Sebastián Eduardo Ibáñez Vodnizza, Edwin Jáuregui, Vanessa Ocampo, Daniel Ruben Palleiro Rivero, Penélope Esther Palominos, Cesar Pacheco Tena, Guillermo Andrés Quiceno, Lina María Saldarriaga-Rivera, Fernando Andrés Sommerfleck, Annelise Goecke Sariego, Claudia Vera Barrezueta, Luis Enrique Vega Espinoza, Oscar Vega Hinojosa, Gustavo Citera, Carlos Lozada, Percival D. Sampaio-Barros, Emilce Schneeberger & Enrique R. Soriano. (2023) Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis. Nature Reviews Rheumatology 19:11, pages 724-737.
Crossref
Crossref
Michiel Tack. (2021) Problems with the MetaBLIND study: An examination of data on blinding patients in trials with patient-reported outcomes. Journal of Health Psychology 28:9, pages 861-881.
Crossref
Crossref
Mi Ryoung Seo, Jina Yeo, Jun Won Park, Yeon-Ah Lee, Ju Ho Lee, Eun Ha Kang, Seon Mi Ji, Seong-Ryul Kwon, Seong-Kyu Kim, Tae-Jong Kim, Tae-Hwan Kim, Hye Won Kim, Min-Chan Park, Kichul Shin, Sang-Hoon Lee, Eun Young Lee, Hoon Suk Cha, Seung Cheol Shim, Youngim Yoon, Seung Ho Lee, Jun Hong Lim & Han Joo Baek. (2023) Korean treatment recommendations for patients with axial spondyloarthritis. The Korean Journal of Internal Medicine.
Crossref
Crossref
Andrea Cassinotti, Alberto Batticciotto, Marco Parravicini, Maurizio Lombardo, Paolo Radice, Claudio Camillo Cortelezzi, Simone Segato, Federico Zanzi, Antonella Cappelli & Sergio Segato. (2022) Evidence-based efficacy of methotrexate in adult Crohn’s disease in different intestinal and extraintestinal indications. Therapeutic Advances in Gastroenterology 15, pages 175628482210858.
Crossref
Crossref
Dennis McGonagle, Sibel Z. Aydin, Helena Marzo-Ortega, Lihi Eder & Coziana Ciurtin. (2021) Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?. Seminars in Arthritis and Rheumatism 51:6, pages 1147-1161.
Crossref
Crossref
Gustavo Gomes Resende, Eduardo de Souza Meirelles, Cláudia Diniz Lopes Marques, Adriano Chiereghin, Andre Marun Lyrio, Antônio Carlos Ximenes, Carla Gonçalves Saad, Célio Roberto Gonçalves, Charles Lubianca Kohem, Cláudia Goldenstein Schainberg, Cristiano Barbosa Campanholo, Júlio Silvio de Sousa Bueno Filho, Lenise Brandao Pieruccetti, Mauro Waldemar Keiserman, Michel Alexandre Yazbek, Penelope Esther Palominos, Rafaela Silva Guimarães Goncalves, Ricardo da Cruz Lage, Rodrigo Luppino Assad, Rubens Bonfiglioli, Sônia Maria Alvarenga Anti, Sueli Carneiro, Thauana Luíza Oliveira, Valderílio Feijó Azevedo, Washington Alves Bianchi, Wanderley Marques Bernardo, Marcelo de Medeiros Pinheiro & Percival Degrava Sampaio-Barros. (2020) The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019. Advances in Rheumatology 60:1.
Crossref
Crossref
Rikke A. Andreasen, Lars E. Kristensen, Xenofon Baraliakos, Vibeke Strand, Philip J. Mease, Maarten de Wit, Torkell Ellingsen, Inger Marie J. Hansen, Jamie Kirkham, George A. Wells, Peter Tugwell, Lara Maxwell, Maarten Boers, Kenneth Egstrup & Robin Christensen. (2020) Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews. Arthritis Research & Therapy 22:1.
Crossref
Crossref
Denis Poddubnyy, Howard Amital & Andrea Rubbert-Roth. (2019) Should we combine biologics with methotrexate in axial spondyloarthritis?. Autoimmunity Reviews 18:12, pages 102402.
Crossref
Crossref
Michael M. Ward, Atul Deodhar, Lianne S. Gensler, Maureen Dubreuil, David Yu, Muhammad Asim Khan, Nigil Haroon, David Borenstein, Runsheng Wang, Ann Biehl, Meika A. Fang, Grant Louie, Vikas Majithia, Bernard Ng, Rosemary Bigham, Michael Pianin, Amit Aakash Shah, Nancy Sullivan, Marat Turgunbaev, Jeff Oristaglio, Amy Turner, Walter P. Maksymowych & Liron Caplan. (2019) 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis & Rheumatology 71:10, pages 1599-1613.
Crossref
Crossref
Michael M. Ward, Atul Deodhar, Lianne S. Gensler, Maureen Dubreuil, David Yu, Muhammad Asim Khan, Nigil Haroon, David Borenstein, Runsheng Wang, Ann Biehl, Meika A. Fang, Grant Louie, Vikas Majithia, Bernard Ng, Rosemary Bigham, Michael Pianin, Amit Aakash Shah, Nancy Sullivan, Marat Turgunbaev, Jeff Oristaglio, Amy Turner, Walter P. Maksymowych & Liron Caplan. (2019) 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care & Research 71:10, pages 1285-1299.
Crossref
Crossref
Fabian Proft & Denis Poddubnyy. 2019. Axial Spondyloarthritis. Axial Spondyloarthritis
217
226
.
Jonathan Chan & Dafna Gladman. (2018) Oral treatment options for AS and PsA: DMARDs and small-molecule inhibitors. Best Practice & Research Clinical Rheumatology 32:3, pages 415-426.
Crossref
Crossref
Aswin M. Nair, P. Sandhya, Bijesh Yadav & Debashish Danda. (2017) TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis. Clinical Rheumatology 36:10, pages 2243-2251.
Crossref
Crossref
Nurullah Akkoc, Gercek Can, Salvatore D’Angelo, Angela Padula & Ignazio Olivieri. (2017) Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies. Current Rheumatology Reports 19:2.
Crossref
Crossref
Mehul Jariwala & Ruben Burgos-Vargas. 2017. Pediatric Rheumatology. Pediatric Rheumatology
229
246
.
Heikki Relas, Hannu Kautiainen, Kari Puolakka, Lauri J. Virta & Marjatta Leirisalo-Repo. (2014) Survival of disease-modifying antirheumatic drugs used as the first antirheumatic medication in the treatment of ankylosing spondylitis in Finland. A nationwide population-based register study. Clinical Rheumatology 33:8, pages 1135-1138.
Crossref
Crossref
Joachim Sieper, Benjamin Porter-Brown, Liz Thompson, Olivier Harari & Maxime Dougados. (2014) Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials. Annals of the Rheumatic Diseases 73:1, pages 95-100.
Crossref
Crossref
Charles L. Kohem, Adriana B. Bortoluzzo, Célio R. Gonçalves, José Antonio Braga da Silva, Antonio Carlos Ximenes, Manoel B. Bértolo, Sandra L.E. Ribeiro, Mauro Keiserman, Rita Menin, Thelma L. Skare, Sueli Carneiro, Valderílio F. Azevedo, Walber P. Vieira, Elisa N. Albuquerque, Washington A. Bianchi, Rubens Bonfiglioli, Cristiano Campanholo, Hellen M.S. Carvalho, Izaias Pereira da Costa, Angela L.B. Pinto Duarte, Nocy H. Leite, Sonia A.L. Lima, Eduardo S. Meirelles, Ivânio A. Pereira, Marcelo M. Pinheiro, Elizandra Polito, Gustavo G. Resende, Francisco Airton C. Rocha, Mittermayer B. Santiago, Maria de Fátima L.C. Sauma, Valéria Valim & Percival D. Sampaio-Barros. (2014) Profile of the use of disease modifying drugs in the Brazilian Registry of Spondyloarthritides. Revista Brasileira de Reumatologia (English Edition) 54:1, pages 33-37.
Crossref
Crossref
Charles L. Kohem, Adriana B. Bortoluzzo, Célio R. Gonçalves, José Antonio Braga da Silva, Antonio Carlos Ximenes, Manoel B. Bértolo, Sandra L.E. Ribeiro, Mauro Keiserman, Rita Menin, Thelma L. Skare, Sueli Carneiro, Valderílio F. Azevedo, Walber P. Vieira, Elisa N. Albuquerque, Washington A. Bianchi, Rubens Bonfiglioli, Cristiano Campanholo, Hellen M.S. Carvalho, Izaias Pereira da Costa, Angela L.B. Pinto Duarte, Nocy H. Leite, Sonia A.L. Lima, Eduardo S. Meirelles, Ivânio A. Pereira, Marcelo M. Pinheiro, Elizandra Polito, Gustavo G. Resende, Francisco Airton C. Rocha, Mittermayer B. Santiago, Maria de Fátima L.C. Sauma, Valéria Valim & Percival D. Sampaio-Barros. (2014) Perfil do uso de drogas modificadoras de doença no Registro Brasileiro de Espondiloartrites. Revista Brasileira de Reumatologia 54:1, pages 33-37.
Crossref
Crossref
Amanda J. Steiman, Janet E. Pope, Heather Thiessen-Philbrook, Lihua Li, Cheryl Barnabe, Fares Kalache, Tabitha Kung, Louis Bessette, Cathy Flanagan, Boulos Haraoui, Jacqueline Hochman, Sharon Leclercq, Dianne Mosher, Carter Thorne & Vivian Bykerk. (2013) Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials. Rheumatology International 33:5, pages 1105-1120.
Crossref
Crossref
Junmin Chen, Mirella MS Veras, Chao Liu & Junfang Lin. (2013) Methotrexate for ankylosing spondylitis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Meryem Can, Sibel Z. Aydın, Adil Niğdelioğlu, Pamir Atagündüz & Haner Direskeneli. (2012)
Conventional
DMARD
therapy (methotrexate‐sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: A real‐life experience
. International Journal of Rheumatic Diseases 15:6, pages 526-530.
Crossref
Crossref
Alexandra N Colebatch, Jonathan L Marks & Christopher J Edwards. (2011) Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Denis Mulleman, Francine Lauféron, Daniel Wendling, David Ternant, Emilie Ducourau, Gilles Paintaud & Philippe Goupille. (2011) Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study. Arthritis Research & Therapy 13:3, pages R82.
Crossref
Crossref
Joachim Sieper. 2011. Rheumatology. Rheumatology
1157
1177.e3
.
Alyssa K. Johnsen & Michael E. Weinblatt. 2011. Rheumatology. Rheumatology
509
517.e3
.
Ignazio Olivieri, Salvatore D’Angelo, Carlo Palazzi & Angela Padula. (2010) Advantages in early recognition and treatment of psoriatic arthritis. International Journal of Clinical Rheumatology 5:4, pages 461-473.
Crossref
Crossref
Alejandro Prada Ojeda, Teresa Otón Sánchez & Jesús Sanz Sanz. (2010) Utilidad de los fármacos modificadores de enfermedad (FAME) en el tratamiento de las espondiloartropatías. Seminarios de la Fundación Española de Reumatología 11:3, pages 107-114.
Crossref
Crossref
AN Malaviya, S Shankar, V Arya, V Dhir, V Agarwal, S Pandya, K Shanmuganandan, VP Chaturvedi & CJ Das. (2010) Indian Rheumatology Association consensus statement on the diagnosis and treatment of axial spondyloarthropathies. Indian Journal of Rheumatology 5:1, pages 16-34.
Crossref
Crossref
L. Goh & A. Samanta. (2009) A systematic medline analysis of therapeutic approaches in ankylosing spondylitis. Rheumatology International 29:10, pages 1123-1135.
Crossref
Crossref
E. K. Li, J. F. Griffith, V. W. Lee, Y.-X. Wang, T. K. Li, K. K. Lee & L.-S. Tam. (2008) Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a clinical and magnetic resonance imaging correlation. Rheumatology 47:9, pages 1358-1363.
Crossref
Crossref
P. I. Sidiropoulos, G. Hatemi, I.-H. Song, J. Avouac, E. Collantes, V. Hamuryudan, M. Herold, T. K. Kvien, H. Mielants, J. M. Mendoza, I. Olivieri, M. Østergaard, L. Schachna, J. Sieper, D. T. Boumpas & M. Dougados. (2008) Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology 47:3, pages 355-361.
Crossref
Crossref
Carmen Meier & Scott Plevy. (2007) Therapy Insight: how the gut talks to the joints—inflammatory bowel disease and the spondyloarthropathies. Nature Clinical Practice Rheumatology 3:11, pages 667-674.
Crossref
Crossref
Liisa Konttinen, Riitta Tuompo, Tea Uusitalo, Riitta Luosujärvi, Kari Laiho, Jukka Lähteenmäki, Maija Puurtinen-Vilkki, Ritva Lanteri, Saara Kortelainen, Helena Karilainen, Tuire Varjolahti-Lehtinen & Dan Nordström. (2007) Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experience. Clinical Rheumatology 26:10, pages 1693-1700.
Crossref
Crossref
J. Braun, J. Zochling, E. Märker-Hermann, G. Stucki, H. Böhm, M. Rudwaleit, H. Zeidler & J. Sieper. (2006) Empfehlungen für das Management der ankylosierenden Spondylitis gemäß ASAS/EULARRecommendations for the management of ankylosing spodylitis after ASAS/EULAR: evaluation in the German language area. Zeitschrift für Rheumatologie 65:8, pages 728-742.
Crossref
Crossref
Junmin Chen, Chao Liu & Junfang Lin. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Nurullah Akkoc, Sjef van der Linden & Muhammad Asim Khan. (2006) Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy. Best Practice & Research Clinical Rheumatology 20:3, pages 539-557.
Crossref
Crossref
John D. Reveille & Frank C. Arnett. (2005) Spondyloarthritis: update on pathogenesis and management. The American Journal of Medicine 118:6, pages 592-603.
Crossref
Crossref
James L. Moeller. (2005) Inflammatory Bowel Disease Arthropathy. Current Sports Medicine Reports 4:2, pages 105-107.
Crossref
Crossref
Silvio Danese. (2005) Extraintestinal manifestations in inflammatory bowel disease. World Journal of Gastroenterology 11:46, pages 7227.
Crossref
Crossref
??ric Toussirot & Daniel Wendling. (2005) Late-Onset Ankylosing Spondylitis and Related Spondylarthropathies. Drugs & Aging 22:6, pages 451-469.
Crossref
Crossref
M. De Vos. (2004) Joint involvement in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 20, pages 36-42.
Crossref
Crossref
J Chen & C Liu. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.